111 related articles for article (PubMed ID: 20635741)
1. Nesiritide: first use in India.
Manchanda A; Kohli V
Indian Heart J; 2009; 61(4):371-2. PubMed ID: 20635741
[No Abstract] [Full Text] [Related]
2. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
Riter HG; Redfield MM; Burnett JC; Chen HH
J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
[No Abstract] [Full Text] [Related]
3. Nesiritide speeds recovery time for heart failure patients.
Morrow T
Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
[No Abstract] [Full Text] [Related]
4. Nesiritide in acute heart failure.
Burger AJ; Silver MA
Lancet; 2003 Sep; 362(9388):998; author reply 998-9. PubMed ID: 14511939
[No Abstract] [Full Text] [Related]
5. Nesiritide in acute heart failure.
Drazner M; McGuire DK; de Lemos JA
Lancet; 2003 Sep; 362(9388):998-9. PubMed ID: 14511940
[No Abstract] [Full Text] [Related]
6. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
Munger MA; Ng TM; Van Tassell BW
Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of nesiritide in pediatric heart failure.
Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
[TBL] [Abstract][Full Text] [Related]
8. Nesiritide in infants and children with congestive heart failure.
Mahle WT; Cuadrado AR; Kirshbom PM; Kanter KR; Simsic JM
Pediatr Crit Care Med; 2005 Sep; 6(5):543-6. PubMed ID: 16148814
[TBL] [Abstract][Full Text] [Related]
9. Nesiritide compared with milrinone for cardiac surgery.
Blais DM
Ann Pharmacother; 2007 Mar; 41(3):502-4. PubMed ID: 17327288
[TBL] [Abstract][Full Text] [Related]
10. Does nesiritide offer something new in the management of pediatric heart failure?
Baden HP
Pediatr Crit Care Med; 2005 Sep; 6(5):613-4. PubMed ID: 16148832
[No Abstract] [Full Text] [Related]
11. Preliminary experience with nesiritide in pediatric patients less than 12 months of age.
Ryan A; Rosen DA; Tobias JD
J Intensive Care Med; 2008; 23(5):321-8. PubMed ID: 18603536
[TBL] [Abstract][Full Text] [Related]
12. Nesiritide therapy in a term neonate with renal disease.
Moffett BS; Jefferies JL; Rossano J; Towbin JA
Pharmacotherapy; 2006 Feb; 26(2):281-4. PubMed ID: 16466334
[TBL] [Abstract][Full Text] [Related]
13. Nesiritide for treatment of heart failure due to right ventricular dysfunction.
Sharp RP; Gregory A; Mowdy MH; Sirajuddin R
Pharmacotherapy; 2004 Sep; 24(9):1236-40. PubMed ID: 15460186
[TBL] [Abstract][Full Text] [Related]
14. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
Silver MA
Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
[TBL] [Abstract][Full Text] [Related]
15. Nesiritide: a unique therapeutic cardiac peptide.
Rayburn BK; Bourge RC
Rev Cardiovasc Med; 2001; 2 Suppl 2():S25-31. PubMed ID: 12439359
[TBL] [Abstract][Full Text] [Related]
16. Clinical improvement with repeated courses of intravenous B-type natriuretic peptide in refractory heart failure.
Spevack DM; Matros T; Shah A; Dweck E; Tunick PA
Eur J Heart Fail; 2004 Aug; 6(5):611-3. PubMed ID: 15302009
[No Abstract] [Full Text] [Related]
17. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
Baroletti SA; Wahlstrom HD
Pharmacotherapy; 2004 Nov; 24(11):1634-7. PubMed ID: 15537565
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Saltzberg MT
Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
[TBL] [Abstract][Full Text] [Related]
20. Nesiritide during extracorporeal membrane oxygenation.
Smith T; Rosen DA; Russo P; Berkenbosch JW; Gustafson RA; Siu BL; Rosen KR; Tobias JD
Paediatr Anaesth; 2005 Feb; 15(2):152-7. PubMed ID: 15675934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
